“Low dose BRAF inhibitor” and “high dose BRAF inhibitor” indicate replicates of a monoclonal human melanoma cell line, WM989 A6-G3,14 transfected with a barcode library and treated with 250 nM and 1μM vemurafenib respectively. This evidence concerns the gene BRAF and melanoma.